Kura Oncology, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.22x
Net debt / equity: -0.14x
Debt / assets: 0.04x
Debt / EBITDA: -0.08x
Net debt / EBITDA: 0.05x

Liquidity & coverage

Current ratio: 6.15x
Quick ratio: 6.14x
Cash ratio: 5.72x
Interest coverage: -216.74x
EBITDA / interest: -199.37x
Working capital: $522.3M

Cash & dividend

FCF / debt: -3.48x
Cash flow / debt: -3.21x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.